Rob Etherington Email

CEO/President . Clene Nanomedicine

Current Roles

Employees:
80
Revenue:
$16.1M
About
Clene Nanomedicine, Inc. is a privately-held, clinical-stage biopharmaceutical company focused on the development of unique therapeutics for neurodegenerative diseases. Clene has innovated a novel nanotechnology drug platform for the development of a new class of orally-administered neurotherapeutic drugs. Clene has also advanced into the clinic an aqueous solution of ionic zinc and silver for anti-viral and anti-microbial uses. Founded in 2013, the company is based in Salt Lake City, Utah with R&D and manufacturing operations located in North East, Maryland. This is an exciting time for us. We have been receiving many requests for more information. We hope you understand we cannot respond to individual requests. We instead invite you to visit our website, read our press releases, and check back for updates. For more information, please visit www.clene.com.
Clene Nanomedicine Address
3165 East Millrock Drive
SALT LAKE CITY, UT
United States
Clene Nanomedicine Email

Past Companies

Clene NanomedicineCEO/President

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.